How does House Bill 4468 define 'gender transition' for the purpose of insurance mandates?
Short answer
House Bill 4468 defines "gender transition" as a medical process where an individual’s anatomy, physiology, or mental state is treated or altered. The purpose of these alterations, according to the bill text, is to assist the individual in identifying as a member of the opposite biological sex or a demographic category that does not correspond to their biological sex https://legiscan.com/MI/text/HB4468/id/3445315. This definition determines which patients are subject to the new insurance coverage requirements for monitoring, adverse consequences, and reversal procedures.
What the bill or law says
The legislation adds a new section to the Insurance Code of 1956. It provides specific statutory definitions to clarify the scope of the mandate. The term "gender transition" is defined broadly to include various medical interventions. Specifically, the text lists the removal of otherwise healthy organs or tissue, the introduction of implants, plastic surgery, hormone treatment, and the use of drugs, counseling, or therapy https://legislature.mi.gov/documents/2025-2026/billengrossed/House/htm/2025-HEBH-4468.htm.
The bill also defines "gender transition procedure or treatment" as any medical procedure or treatment performed for the purpose of assisting an individual with gender transition. These definitions are central to the bill because the insurance mandates only apply to enrollees who have undergone such procedures or treatments while covered by the policy https://legiscan.com/MI/text/HB4468/id/3445315.
How it works in practice
Under the proposed law, insurers must look at whether a patient received care that fits this definition. If an enrollee underwent a procedure that altered their anatomy or physiology to assist in identifying as the opposite biological sex, the insurer must provide coverage for three specific areas. These include all possible adverse consequences, annual mental and physical health monitoring, and any treatments necessary to reverse the transition https://legislature.mi.gov/documents/2025-2026/billanalysis/House/pdf/2025-HLA-4468-KN7WTQZP.pdf.
The coverage requirement is tied to the timing of the initial care. The mandate applies only if the enrollee was covered under the policy at the time the initial gender transition procedure or treatment occurred. This means insurers would need to track when specific types of care were delivered to determine their liability for future monitoring or reversal costs https://legiscan.com/MI/text/HB4468/id/3445315.
What the source does not answer
The bill text does not specify how insurers should verify the intent behind a medical procedure. For example, it does not detail how to distinguish between hormone treatments for gender transition and those prescribed for other medical conditions. Additionally, the sources do not provide a list of specific medical codes that would trigger these mandates. There is also no information on how disputes over whether a procedure fits the definition will be resolved between providers and insurers https://legiscan.com/MI/bill/HB4468/2025.